Enno Storz

University Hospital Cologne — Germany

Medicine · Health Sciences

7h-index353citations36works2.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bladder and Urothelial Cancer Treatments(11), Prostate Cancer Treatment and Research(7), Urinary and Genital Oncology Studies(5), Radiopharmaceutical Chemistry and Applications(4), Genital Health and Disease(4)

Publications36 total

A real-world evidence study assessing the prevalence of FGFR alterations in patients with non-muscle invasive bladder cancer, as defined by the international bladder cancer group
European Urology Open Science·2025Open Access
Expression and therapeutic potential of TROP2 in cisplatin-resistant germ cell tumors
Journal of Cancer Research and Clinical Oncology·2025· 1 citedOpen Access
TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy
World Journal of Urology·2025· 1 citedOpen Access
3100P NECTIN-4 expression and amplification in CNS metastases of metastatic urothelial carcinoma: Implications for enfortumab vedotin plus pembrolizumab therapy
Annals of Oncology·2025
Sexual Medicine and Male InfertilityAltered Endothelin Receptor Expression in Idiopathic Male Infertility: A Potential Therapeutic Target
Urology Research and Practice·2025Open Access
MP37-12 COST-EFFECTIVENESS ANALYSIS IN THE NEW ERA OF TREATMENT STRATEGIES IN METASTATIC UROTHELIAL CARCINOMA BASED ON CHECKMATE-901 AND EV302/KEYNOTE-A39
The Journal of Urology·2025
A0673 – A real-world evidence study evaluating the prevalence of FGFR alterations in patients with intermediate risk non-muscle invasive bladder cancer, as defined by the International Bladder Cancer Group (IBCG)
European Urology·2025
P091 – Theranostic instillation therapy targeting CXCR4 in combination with systemic chemotherapy for muscle invasive bladder cancer – the "Bladder BRIDGister" experience
European Urology·2025
A0672 – Detection of FGFR3 mutations and fusions in bladder cancer samples: Comparison of the MODAPLEX FGFR panel with therascreen FGFR Kit
European Urology·2025
Frequent overexpression of NECTIN-4 in CNS metastases from urothelial carcinoma.
Journal of Clinical Oncology·2025
Evaluating cost-effectiveness in the evolving treatment landscape for metastatic urothelial carcinoma.
Journal of Clinical Oncology·2025
Pathological complete response and potential for bladder preservation by theranostic instillation therapy targeting CXCR4 in combination with systemic chemotherapy: The Bladder BRIDGister experience.
Journal of Clinical Oncology·2025
Vim3 and Mxi‐2 as Promising New Molecular Biomarkers for the Diagnosis of Sperm Disorders
Andrologia·2025Open Access
Cost-effectiveness Analysis in the New Era of Treatment Strategies in Metastatic Urothelial Carcinoma Based on Checkmate-901 and EV302/Keynote-A39
European Urology Oncology·2024· 11 citedOpen Access
Among renal cell carcinoma subtypes, only papillary renal cell carcinoma demonstrated relevant TROP-2 positivity as a rationale for antibody-drug conjugates targeting TROP-2
2024Open Access
Preservation of the native urethral plate and corpus spongiosum combined with buccal mucosa graft plus Orandi's penile skin flap as an alternative to staged urethroplasty for narrow penile strictures
International Journal of Urology·2024· 1 cited
Trophoblast cell surface antigen‐2: a promising new biomarker and potential therapeutic target in penile squamous cell carcinoma
British Journal of Urology·2024· 13 citedOpen Access
HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center
Urologic Oncology Seminars and Original Investigations·2024· 10 citedOpen Access
MP15-01 NOVEL URINE-BASED BIOMARKER TO DISTINGUISH MUSCLE-INVASIVE FROM NON-MUSCLE INVASIVE BLADDER CANCER–A MULTICENTRIC APPROACH
The Journal of Urology·2024
MP61-08 TROP-2—A PROMISING NEW THERAPEUTIC TARGET IN PENILE SQUAMOUS CELL CARCINOMA
The Journal of Urology·2024
page 1 of 2Next →

Frequent Co-authors

Axel Heidenreich(22), Melanie von Brandenstein(13), Constantin Rieger(12), Richard Weiten(11), Ralph M. Wirtz(9), Yuri Tolkach(8), Carolina Kessler(6), Tim Nestler(6), Philipp Krausewitz(6), Matthias Heck(5), Margitta Retz(5), Tobias Maurer(5), Jürgen E. Gschwend(5), David Pfister(5), Richard Weiten(5), Thorsten Ecke(5), Markus Schwaiger(4), Laurenz Sperber(4), Hanna Elisa Spohn(4), Markus Eckstein(4)